Investor Relations

Home > Investor Relations > Financial Highlights (consolidated)

Financial Highlights (consolidated)

Change of Principal Management Figures

Settlement of accounts time FY2013
(2013/4/1-2014/3/31)
FY2014
(2014/4/1-2015/3/31)
FY2015
(2015/4/1-2016/3/31)
FY2016
(2016/4/1-2017/3/31)
Net sales
(million yen)
61,351 71,470 82,115 84,949
Operating income
(million yen)
7,706 11,105 11,134 6,869
Ordinary income
(million yen)
8,834 15,437 10,157 7,417
Profit attributable to owners of parent
(million yen)
5,992 11,118 7,684 5,576
Total shareholders' equity
(million yen)
60,147 70,048 70,605 74,945
Total assets
(million yen)
103,318 121,187 156,851 165,247
Shareholders' equity per share
(yen)
3,539.07 4,121.66 4,304.37 4,568.97
Net income per share
(yen)
352.61 654.20 462.57 339.96
Shareholders' equity ratio to total assets 58.2% 57.8% 45.0% 45.4%
Cash dividends per share
(yen)
75.00 95.00 95.00 95.00

Net Sales

Operating Income / Ordinary Income / Net Income

Net Income per Share / Cash Dividends per Share

Shareholders' Equity to Total Assets


Home > Investor Relations > Financial Highlights (consolidated)
© Copyright TOWA PHARMACEUTICAL CO.,LTD. All Rights Reserved.